Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature-Reference-Cited by-同舟云学术

Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature

Published:2021-12 Issue:12 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Baksh Mizba¹^ORCID,Jiang Liuyan²,Bhatia Unnati¹^ORCID,Alegria Victoria¹,Sher Taimur¹,Roy Vivek¹,Chanan‐Khan Asher¹³⁴,Ailawadhi Sikander¹³^ORCID,Parrondo Ricardo D.¹^ORCID

Affiliation:

1. Division of Hematology‐Oncology Mayo Clinic Jacksonville Florida USA

2. Department of Pathology Mayo Clinic Jacksonville Florida USA

3. Department of Cancer Biology Mayo Clinic Jacksonville Florida USA

4. Hematology‐Oncology St. Vincent's Riverside Jacksonville Florida USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5181

Reference48 articles.

1. Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005

2. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

3. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

4. IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

5. IgM myeloma: a rare entity characterized by a CD20−CD56−CD117−immunophenotype and the t(11;14)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study;Journal of Hematology;2022-12

2. Cyclophosphamide/dexamethasone/rituximab;Reactions Weekly;2022-02